Session Details
[1AS2-06]【E】New Frontiers in TGF-ß Research: Toward Understanding Life Science and Developing Innovative Therapies
Tue. Dec 1, 2026 11:15 AM - 12:45 PM JST
Tue. Dec 1, 2026 2:15 AM - 3:45 AM UTC
Tue. Dec 1, 2026 2:15 AM - 3:45 AM UTC
Room 6 (Conference Center 3F 311+312)
Organizers: Susumu Itoh (Showa Pharmaceutical University), Keiji Miyazawa (University of Yamanashi)
This symposium will highlight diverse perspectives on dysregulation of TGF-ß signaling and its control, aiming to advance our understanding of biological systems and to foster the development of innovative therapeutic strategies. Specifically, the symposium will cover: medical applications of parasite-derived TGF-ß mimics (ten Dijke); spatiotemporal analysis of signaling dynamics using advanced imaging technologies (Imamura); vascular and lymphatic abnormalities in disease (F.Itoh); and the development of novel models for Smad activation (Y.Itoh). Through these topics, we will discuss the interdisciplinary expansion of TGF-ß research and its broad impact on life sciences and medicine.
[1AS2-06-01]TGF-β Family signaling regulates vascular homeostasis
○Fumiko Itoh1 (1. University of Toyama)
[1AS2-06-02]A Genetically Engineered Organoid Model to Dissect TGF-β-Driven Tumor–Stromal Interactions in Cholangiocarcinoma
○Takeshi Imamura1 (1. Depart. Mol. Med. for Pathogenesis, Ehime Univ. Grad. Sch. of Med.)
[1AS2-06-03]Molecular characterization of a melorheostosis-associated SMAD3 mutant unveils a requirement for functional Smad activation
○Yuka Itoh1,2, Hao Fu2,3, Masao Saitoh2, Keiji Miyazawa2 (1. Nagoya City University, 2. University of Yamanashi, 3. Nagoya University)
[1AS2-06-04]Molecular mimicry by parasites inspires the creation of novel TGF-β cell-selective modulators
○Peter ten Dijke1 (1. Leiden University Medical Center)
